{
    "root": "d1387fa9-4df4-4485-ab77-f756daa18b95",
    "code": "34391-3",
    "codeSystem": "2.16.840.1.113883.6.1",
    "displayName": "HUMAN PRESCRIPTION DRUG LABEL",
    "name": "Liothyronine Sodium",
    "value": "20250520",
    "ingredients": [
        {
            "name": "LIOTHYRONINE SODIUM",
            "code": "GCA9VV7D2N"
        }
    ],
    "indications": "liothyronine sodium l-triiodothyronine ( t3 ) indicated : • hypothyroidism : replacement primary ( thyroidal ) , secondary ( pituitary ) , tertiary ( hypothalamic ) congenital acquired hypothyroidism ( 1.1 ) • pituitary thyroid-stimulating hormone ( tsh ) suppression : adjunct surgery radioiodine therapy management well-differentiated thyroid cancer ( 1.2 ) • thyroid suppression test : diagnostic agent suppression tests differentiate suspected mild hyperthyroidism thyroid gland autonomy ( 1.3 ) limitations : - indicated suppression benign thyroid nodules nontoxic diffuse goiter iodine-sufficient patients . ( 1 ) - indicated treatment hypothyroidism recovery phase subacute thyroiditis . ( 1 )",
    "contraindications": "• administer liothyronine sodium orally daily individual according patient response laboratory findings ( 2.1 ) • full prescribing information recommended hypothyroidism ( 2.2 ) tsh suppression well-differentiated thyroid cancer ( 2.3 ) thyroid suppression test ( 2.4 ) • switching patient liothyronine sodium , discontinue levothyroxine therapy initiate liothyronine sodium low . gradually increase dose according patient 's response ( 2.5 ) • adequacy therapy determined periodic monitoring tsh t3 levels well status ( 2.6 )",
    "warningsAndPrecautions": "liothyronine sodium tablets ( round , white off-white ) supplied follows : strength tablet markings ndc – bottles 100 5 mcg debossed kpi one side 115 side 59762-1206-1 25 mcg scored one side debossed kpi 116 side 59762-1207-1 50 mcg scored one side debossed kpi 117 side 59762-1208-1",
    "adverseReactions": "liothyronine sodium contraindicated patients uncorrected adrenal insufficiency [ ( 5.3 ) ] .",
    "indications_original": "Liothyronine sodium is an L-triiodothyronine (T3) indicated for: • Hypothyroidism: As replacement in primary (thyroidal), secondary (pituitary), and tertiary (hypothalamic) congenital or acquired hypothyroidism ( 1.1 ) • Pituitary Thyroid-Stimulating Hormone (TSH) Suppression: As an adjunct to surgery and radioiodine therapy in the management of well-differentiated thyroid cancer ( 1.2 ) • Thyroid Suppression Test: As a diagnostic agent in suppression tests to differentiate suspected mild hyperthyroidism or thyroid gland autonomy ( 1.3 ) Limitations of Use : - Not indicated for suppression of benign thyroid nodules and nontoxic diffuse goiter in iodine-sufficient patients. ( 1 ) - Not indicated for treatment of hypothyroidism during the recovery phase of subacute thyroiditis. ( 1 )",
    "contraindications_original": "• Administer liothyronine sodium orally once daily and individual dosage according to patient response and laboratory findings ( 2.1 ) • See full prescribing information for recommended dosage for hypothyroidism ( 2.2 ) TSH suppression in well-differentiated thyroid cancer ( 2.3 ) and for thyroid suppression test ( 2.4 ) • When switching a patient to liothyronine sodium, discontinue levothyroxine therapy and initiate liothyronine sodium at a low dosage. Gradually increase the dose according to the patient's response ( 2.5 ) • Adequacy of therapy determined with periodic monitoring of TSH and T3 levels as well as clinical status ( 2.6 )",
    "warningsAndPrecautions_original": "Liothyronine sodium tablets (round, white to off-white) are supplied as follows:\n                  \n                     \n                     \n                     \n                     \n                        \n                           \n                              Strength\n                           \n                           \n                              Tablet Markings\n                           \n                           \n                              NDC – bottles of 100\n                           \n                        \n                     \n                     \n                        \n                           \n                              5 mcg\n                           \n                           \n                              Debossed with KPI on one side and 115 on the other side\n                           \n                           \n                              59762-1206-1\n                           \n                        \n                        \n                           \n                              25 mcg\n                           \n                           \n                              Scored on one side and debossed with KPI and 116 on the other side\n                           \n                           \n                              59762-1207-1\n                           \n                        \n                        \n                           \n                              50 mcg\n                           \n                           \n                              Scored on one side and debossed with KPI and 117 on the other side\n                           \n                           \n                              59762-1208-1",
    "adverseReactions_original": "Liothyronine sodium is contraindicated in patients with uncorrected adrenal insufficiency [see \n                     \n                     \n                        Warnings and Precautions (5.3)\n                        ]\n                     \n                     ."
}